Hui‐Hsin Chang

719 total citations
18 papers, 594 citations indexed

About

Hui‐Hsin Chang is a scholar working on Immunology, Molecular Biology and Pharmacology. According to data from OpenAlex, Hui‐Hsin Chang has authored 18 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Hui‐Hsin Chang's work include Fungal Biology and Applications (7 papers), Herbal Medicine Research Studies (5 papers) and Protein Tyrosine Phosphatases (4 papers). Hui‐Hsin Chang is often cited by papers focused on Fungal Biology and Applications (7 papers), Herbal Medicine Research Studies (5 papers) and Protein Tyrosine Phosphatases (4 papers). Hui‐Hsin Chang collaborates with scholars based in Taiwan and United States. Hui‐Hsin Chang's co-authors include Fuu Sheu, I‐Cheng Ho, Nishant Dwivedi, Chen‐Hao Yeh, Anthony P. Nicholas, Shi‐Chuen Miaw, William W. Tseng, Po‐Jung Chien, Hsiao‐Wei Tsao and Tzong-Shyuan Tai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Hui‐Hsin Chang

18 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui‐Hsin Chang Taiwan 14 275 237 145 102 82 18 594
Qingyi Lu China 10 192 0.7× 254 1.1× 48 0.3× 110 1.1× 32 0.4× 17 580
Yani Zhao China 10 181 0.7× 226 1.0× 53 0.4× 69 0.7× 48 0.6× 21 604
Steven Dudics United States 7 196 0.7× 197 0.8× 33 0.2× 115 1.1× 28 0.3× 7 547
Brian Astry United States 10 312 1.1× 236 1.0× 46 0.3× 136 1.3× 19 0.2× 11 720
Hui Tian China 10 126 0.5× 219 0.9× 44 0.3× 15 0.1× 96 1.2× 21 538
Emanuela Massi Italy 8 213 0.8× 342 1.4× 35 0.2× 38 0.4× 88 1.1× 8 672
Xiaoming Wu China 15 101 0.4× 303 1.3× 41 0.3× 88 0.9× 79 1.0× 46 709
Dezhi Song China 15 97 0.4× 482 2.0× 61 0.4× 53 0.5× 39 0.5× 37 717
Zhiqiang Liu China 15 187 0.7× 219 0.9× 44 0.3× 17 0.2× 33 0.4× 58 638
Hong Kyung Lee South Korea 19 368 1.3× 259 1.1× 89 0.6× 28 0.3× 12 0.1× 38 841

Countries citing papers authored by Hui‐Hsin Chang

Since Specialization
Citations

This map shows the geographic impact of Hui‐Hsin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Hsin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Hsin Chang more than expected).

Fields of papers citing papers by Hui‐Hsin Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Hsin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Hsin Chang. The network helps show where Hui‐Hsin Chang may publish in the future.

Co-authorship network of co-authors of Hui‐Hsin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Hsin Chang. A scholar is included among the top collaborators of Hui‐Hsin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Hsin Chang. Hui‐Hsin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sun, Bo, Hui‐Hsin Chang, Ari J. Salinger, et al.. (2019). Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination. JCI Insight. 4(22). 36 indexed citations
2.
Chang, Hui‐Hsin, Andréa Alice Silva, Jeffrey A. Sparks, et al.. (2019). Utilizing a PTPN22 gene signature to predict response to targeted therapies in rheumatoid arthritis. Journal of Autoimmunity. 101. 121–130. 8 indexed citations
3.
Chang, Hui‐Hsin, Guang‐Yaw Liu, Nishant Dwivedi, et al.. (2016). A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22. JCI Insight. 1(17). e90045–e90045. 50 indexed citations
4.
Yen, Wei-Feng, Yu‐Hsien Lin, Hui‐Hsin Chang, et al.. (2015). Reciprocal Regulation of C-Maf Tyrosine Phosphorylation by Tec and Ptpn22. PLoS ONE. 10(5). e0127617–e0127617. 8 indexed citations
5.
Chang, Hui‐Hsin, Nishant Dwivedi, Anthony P. Nicholas, & I‐Cheng Ho. (2015). The W620 Polymorphism in PTPN22 Disrupts Its Interaction With Peptidylarginine Deiminase Type 4 and Enhances Citrullination and NETosis. Arthritis & Rheumatology. 67(9). 2323–2334. 91 indexed citations
6.
Xiong, Yanbao, Michael Murphy, Tissa T. Manavalan, et al.. (2015). Endotoxin Tolerance Inhibits Lyn and c-Src Phosphorylation and Association with Toll-Like Receptor 4 but Increases Expression and Activity of Protein Phosphatases. Journal of Innate Immunity. 8(2). 171–184. 15 indexed citations
7.
Chang, Hui‐Hsin, William W. Tseng, Jing Cui, Karen H. Costenbader, & I‐Cheng Ho. (2014). Altered expression of protein tyrosine phosphatase, non-receptor type 22 isoforms in systemic lupus erythematosus. Arthritis Research & Therapy. 16(1). R14–R14. 14 indexed citations
8.
Chang, Hui‐Hsin, et al.. (2014). Molecular Cloning of aPoria cocosProtein That Activates Th1 Immune Response and Allays Th2 Cytokine and IgE Production in a Murine Atopic Dermatitis Model. Journal of Agricultural and Food Chemistry. 62(13). 2861–2871. 25 indexed citations
9.
Tsao, Hsiao‐Wei, Tzong-Shyuan Tai, William W. Tseng, et al.. (2013). Ets-1 facilitates nuclear entry of NFAT proteins and their recruitment to the IL-2 promoter. Proceedings of the National Academy of Sciences. 110(39). 15776–15781. 43 indexed citations
10.
Chang, Hui‐Hsin, Shi‐Chuen Miaw, William W. Tseng, et al.. (2013). PTPN22 Modulates Macrophage Polarization and Susceptibility to Dextran Sulfate Sodium–Induced Colitis. The Journal of Immunology. 191(5). 2134–2143. 59 indexed citations
11.
Chang, Hui‐Hsin, Tzong-Shyuan Tai, Bing Lü, et al.. (2012). PTPN22.6, a Dominant Negative Isoform of PTPN22 and Potential Biomarker of Rheumatoid Arthritis. PLoS ONE. 7(3). e33067–e33067. 31 indexed citations
12.
Chang, Hui‐Hsin, et al.. (2009). Oral administration of an Enoki mushroom protein FVE activates innate and adaptive immunity and induces anti-tumor activity against murine hepatocellular carcinoma. International Immunopharmacology. 10(2). 239–246. 45 indexed citations
14.
Chang, Hui‐Hsin, Chen‐Hao Yeh, & Fuu Sheu. (2009). A Novel Immunomodulatory Protein from Poria cocos Induces Toll-like Receptor 4-Dependent Activation within Mouse Peritoneal Macrophages. Journal of Agricultural and Food Chemistry. 57(14). 6129–6139. 49 indexed citations
15.
Chien, Po‐Jung, et al.. (2008). High Processing Tolerances of Immunomodulatory Proteins in Enoki and Reishi Mushrooms. Journal of Agricultural and Food Chemistry. 56(9). 3160–3166. 24 indexed citations
17.
Sheu, Fuu, Po‐Jung Chien, H.X. Wang, Hui‐Hsin Chang, & Yuan‐Tay Shyu. (2007). New protein PCiP from edible golden oyster mushroom (Pleurotus citrinopileatus) activating murine macrophages and splenocytes. Journal of the Science of Food and Agriculture. 87(8). 1550–1558. 23 indexed citations
18.
Chang, Hui‐Hsin & Fuu Sheu. (2006). Anti‐tumor mechanisms of orally administered a fungal immunomodulatory protein from Flammulina velutipes in mice. The FASEB Journal. 20(5). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026